Fecal Mucin O-Glycans as Novel Biomarkers in Inflammatory Bowel Diseases

Inflamm Bowel Dis. 2023 Mar 1;29(3):e12. doi: 10.1093/ibd/izac282.

Authors

Catherine Robbe Masselot¹, Camille Cordier², Benjamin Marsac¹, Maria Nachury³, Renaud Léonard¹, Boualem Sendid²

Affiliations

¹ Univ. Lille, CNRS UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle, Lille, France.
² Univ. Lille, CNRS UMR 8576, UGSF, Inserm U1285, CHU Lille, Laboratoire de Parasitologie-Mycologie, Lille, France.
³ Univ. Lille, Inserm, CHU Lille, U1286, INFINITE, Institute for Translational Research in Inflammation, F-59000 Lille, France.

PMID: 36626566
DOI: 10.1093/ibd/izac282

No abstract available

Publication types

Letter
Comment

MeSH terms

Glycosylation
Humans
Inflammatory Bowel Diseases*
Mucins* / metabolism
Polysaccharides

Substances

Mucins
Polysaccharides